Clearside Biomedical Inc (NAS:CLSD)
$ 1.305 -0.005 (-0.38%) Market Cap: 97.54 Mil Enterprise Value: 69.42 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 63/100

Clearside Biomedical Inc OASIS Extension Study Results Call Transcript

Feb 02, 2023 / 01:30PM GMT
Release Date Price: $1.49 (-3.25%)
Unidentified Participant

Good day, and welcome to the Clearside Biomedical OASIS Extension Study Results Conference Call. (Conference Instructions) It is now my pleasure to turn the floor over to your host, Jenny Kobin with Investor Relations. Ma'am, the floor is yours.

Jenny Kobin
Investor Relations Advisory Solutions - IR

Good morning, and thank you for joining us on the call. Before we begin, I would like to remind you that during today's call, we will be making certain forward-looking statements. Various remarks that we make during this call about the company's future expectations, plans, and prospects constitute forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.

Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of our annual report on Form 10-K for the year ended December 31, 2021 and other SEC filings available on our website. In addition, any forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot